Bedminster, NJ, United States of America

Donald Bolser

This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 1991.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Donald Bolser

Introduction

Donald Bolser is a notable inventor based in Bedminster, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of coughs. His innovative approach has led to the development of a unique method that utilizes GABA-B selective agonists as anti-tussive agents.

Latest Patents

Bolser holds a patent for the "Use of GABA-B selective agonists as anti-tussive agents." This patent describes a method for treating cough in mammals by administering an anti-tussive effective amount of a GABA-B selective agonist. The implications of this invention could greatly enhance therapeutic options for patients suffering from persistent coughs.

Career Highlights

Throughout his career, Bolser has been associated with Schering Corporation, where he has been able to apply his expertise in pharmacology and innovation. His work has not only contributed to the company's portfolio but has also advanced the understanding of cough treatment methodologies.

Collaborations

Bolser has collaborated with notable colleagues such as William Kreutner and Richard W. Chapman. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.

Conclusion

Donald Bolser's contributions to the field of medicine through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to inspire advancements in the treatment of coughs, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…